Orphan Drugs and Rare Diseases Conference 2018
In-Person Event
Oct 17 - 18, 2018
London, England, GB
OVERVIEW
8th Annual Orphan Drugs and Rare Diseases Conference is organized by SMi Group and will be held from Oct 17 - 18, 2018 at Holiday Inn London - Kensington Forum, London, England, United Kingdom.
The target audience for this medical event is CEOs, CSOs, CMOs, VPs, Senior and Principle Scientists Researchers, Scientists, Medical Doctors and Professionals in the fields of - Drug Discovery & Development, Personalized, Translational, Stratified, Regenerative and Experimental Medicine, Cell / Molecular Biology, Molecular Diagnostics and Diagnostic Development, Cell / Gene Therapy, Rare & ultra-rare Diseases, Genetic Diseases, Metabolic & Gastrointestinal (GI) disorders, Haematology, Immunology, Endocrinology, Cardiovascular and Respiratory disorders, Cancer / Oncology, Market Access, Pricing & Reimbursement, Patient Advocacy, Regulatory & Medical Affairs, Commercial Development, Bioinformatics, Big Data, Digital Health.
Course Description:
This year's Conference will bring together regulatory agencies, pharmaceutical companies, non-profit organisations and orphan drugs developers to construct an agenda that addresses the driving economic factors, policies and issues that will affect the development of orphan drugs globally including commercialisation, policies, reimbursement, and pricing.
Keep up to date with the industry and to learn from expert speaker panel, bringing you important new case studies and reports on this year’s relevant topics.
Course Objectives:
• Discuss the pricing and reimbursement of orphan drugs
• Understand the challenges of patient recruitment and patient-centric research
• Hear the MHRA's perspective on benefit-risk assessment in rare diseases
• Explore the clinical development of orphan drugs for rare disease
• Gain insight into potential synergies between regulators and assessors
Additional details will be posted as soon as they are available.
The target audience for this medical event is CEOs, CSOs, CMOs, VPs, Senior and Principle Scientists Researchers, Scientists, Medical Doctors and Professionals in the fields of - Drug Discovery & Development, Personalized, Translational, Stratified, Regenerative and Experimental Medicine, Cell / Molecular Biology, Molecular Diagnostics and Diagnostic Development, Cell / Gene Therapy, Rare & ultra-rare Diseases, Genetic Diseases, Metabolic & Gastrointestinal (GI) disorders, Haematology, Immunology, Endocrinology, Cardiovascular and Respiratory disorders, Cancer / Oncology, Market Access, Pricing & Reimbursement, Patient Advocacy, Regulatory & Medical Affairs, Commercial Development, Bioinformatics, Big Data, Digital Health.
Course Description:
This year's Conference will bring together regulatory agencies, pharmaceutical companies, non-profit organisations and orphan drugs developers to construct an agenda that addresses the driving economic factors, policies and issues that will affect the development of orphan drugs globally including commercialisation, policies, reimbursement, and pricing.
Keep up to date with the industry and to learn from expert speaker panel, bringing you important new case studies and reports on this year’s relevant topics.
Course Objectives:
• Discuss the pricing and reimbursement of orphan drugs
• Understand the challenges of patient recruitment and patient-centric research
• Hear the MHRA's perspective on benefit-risk assessment in rare diseases
• Explore the clinical development of orphan drugs for rare disease
• Gain insight into potential synergies between regulators and assessors
Additional details will be posted as soon as they are available.
KEY DATES
17 Oct, 2018
Event Start Date
18 Oct, 2018
Event End Date
SPECIALITIES
Pharmacy and MedicineSUGGESTED HOTELS
CONFERENCE VENUE
Holiday Inn London - Kensington ForumRELATED CONFERENCES & LIVE WEBINARS
Quick Links